CD44 and cancer: However, there is no universal set of biomarkers that can be used to recognize and isolate CSCs CD44 and CD133 transmembrane glycoproteins are widely putative as general CSC markers in many types of tumors, and are involved in normal cellular processes and also in cancer development (122).